These findings collectively affirm the critical role of the EGR1/PTEN axis in modulating the oncogenic traits and stem cell-like properties of EC cells, revealing a compelling target for therapeutic intervention in endometrial carcinoma. Here, PTEN is linked to endometrial carcinoma.